Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Thiopurines Related Toxicity Through the Determination by DHPLC TPMT Polymorphisms in Patients With ALL.

NCT00402090 is registered in ClinicalTrials.gov with National Institute of Cancerología as lead sponsor.

NCT NCT00402090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Thiopurines Related Toxicity Through the Determination by DHPLC TPMT Polymorphisms in Patients With ALL.
Lead sponsor
National Institute of Cancerología
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2005
Completion date
November 30, 2006
Enrollment
160
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia